Johns Hopkins All Children's Hospital president shares her personal journey and vision for elevating the hospital to a ...

Teams from across the university pitched plans for a personal safety device worn on a shoe, an AI platform to cut medical ...

More than a dozen data-gathering programs that track deaths and disease appear to have been eliminated in the tornado of ...

The school’s latest mural, "Nourishing Growth," was partially designed and painted by students, as part of a collaboration ...

Further diagnostic tests revealed that Charles has “a form of cancer.” In the months since the announcement, no further ...

The global burden of chronic kidney disease (CKD) is rising, with more than 800 million people affected worldwide. Vascular diseases in patients with CKD are unique and grouped as uremic vascular ...

Tiziana Life Sciences (TLSA) announced that dosing has commenced at the fourth clinical site in its ongoing Phase 2 trial evaluating intranasal ...

Luminopia, Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, today announced that the U.S. Food & Drug Administration (FDA) cleared its amblyopia ...

Let's go Ian!" The addition of Jackson — which followed the additions of Arizona State transfer Joson Sanon, Providence transfer Bryce Hopkins and Stanford transfer Oziyah Sellers — means St ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...

The curiosity of young children can sometimes land them in the emergency room. Pediatric Emergency Physician Patrick Mularoni, M.D., shares about the "foreign bodies" that kids can ingest or that ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a study by researchers from the Johns ...